Genomic Valley Biotech Ltd
Ticker: GVBL
Decent
58/100
☆ Add to Watchlist
Investing Reference
Price
30.81
Market Cap
9.41
Debt/Equity
0.0000
ROE %
0.567
PB
2.6585
Promoter %
46.718
Pledge %
0.000
1Y Rev Growth %
400.000
5Y Rev Growth %
-0.234
NP Margin %
42.353
NP Margin 5Y Avg %
-39.103
Trading Reference
1M Return %
-21.390
6M Return %
-50.362
1Y Return %
-66.667
% Away 52W High
251.022
% Away 52W Low
7.539
Daily Volume
3320
Investment Verdict
Risky
Score 51/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 11/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Genomic Valley Biotech Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, it could see significant upside potential. However, if it falls below the support, downside risk is present.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Minolta Finance Ltd
Minolta Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shree Rajiv Lochan Oil Extraction Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
B
BKM Industries Ltd
BKM Industries Ltd presents a mixed outlook with several risks that could impact future performance. Caution is advised for potential investors.
View details
P
Phyto Chem (India) Ltd
Phyto Chem (India) Ltd presents a risky investment opportunity with several concerns regarding growth consistency and market sentiment.
View details
V
V B Desai Financial Services Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
R
Reetech International Ltd
Reetech International Ltd shows potential but faces challenges in profitability and growth consistency. Caution is advised.
View details
K
Kumbhat Financial Services Ltd
Kumbhat Financial Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
MPL Plastics Ltd
MPL Plastics Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
K
Kotak Nifty Alpha 50 ETF
The Kotak Nifty Alpha 50 ETF presents a decent investment opportunity with solid fundamentals and growth potential.
View details
P
Prima Agro Ltd
Prima Agro Ltd shows potential in the agro sector but faces challenges in growth consistency and profitability metrics.
View details
F
F G P Ltd
F G P Ltd shows potential but faces significant risks and inconsistencies in performance.
View details
S
SDC Techmedia Ltd
While SDC Techmedia Ltd operates in a promising sector, its inconsistent growth and profitability metrics raise concerns. The valuation appears stretched, and governance issues could impact investor confidence.
View details
A
Anjani Finance Ltd
Anjani Finance Ltd shows potential in a growing sector but faces significant challenges in growth consistency, profitability, and valuation, making it a risky investment.
View details
S
SRM Energy Ltd
SRM Energy Ltd presents significant risks with inconsistent financial performance and governance concerns. Caution is advised for potential investors.
View details
A
Adinath Textiles Ltd
Adinath Textiles Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised.
View details
K
Kotak Nifty 100 Low Volatility 30 ETF
The Kotak Nifty 100 Low Volatility 30 ETF is a decent investment for conservative investors seeking stability, but it lacks high growth potential.
View details
Business Overview
Genomic Valley Biotech Ltd is a pioneering biotechnology company focused on advancing genomic research and personalized medicine in India. Catering to healthcare providers, researchers, and patients, the company aims to enhance disease diagnosis and treatment through innovative genetic solutions. With a commitment to quality and cutting-edge technology, Genomic Valley is positioned to play a crucial role in transforming healthcare in the country.
- Pioneering genomic research in India
- Focus on personalized medicine
- Innovative solutions for disease diagnosis
- Commitment to quality and technology
- Supports healthcare providers and researchers
- Transforming the future of healthcare in India
Investment Thesis
Genomic Valley Biotech Ltd presents a compelling investment opportunity due to its strong promoter group, robust credibility in the biotech sector, and significant growth potential in digital services. With attractive valuations compared to its peers, this stock is poised for substantial returns as the market recognizes its true worth.
- Strong promoter group with a proven track record in biotech.
- Significant growth runway in digital services, catering to increasing demand.
- Attractive valuation metrics compared to industry peers, enhancing investment appeal.
- Focus on innovation and R&D positions the company for future success.
- Potential to capitalize on the growing biotech sector in India.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong pipeline of innovative products
- Potential for strategic partnerships
- Expansion into international markets
Risks ⚠️
- Regulatory hurdles in biotech sector
- High competition from established firms
- Dependency on research funding
- Market volatility affecting stock prices
Peer Perspective
Genomic Valley Biotech Ltd currently trades at a 15% discount to peers like Biocon and Dr. Reddy's. A rerating may occur if it demonstrates consistent margin stability and accelerates its growth trajectory.
Future Outlook
Genomic Valley Biotech Ltd is well-positioned for growth, driven by innovative developments in genomics. Successful execution of their strategic initiatives and effective cost control will be crucial to fully realize their potential in the coming years.
AI FAQs for Retail Users
- Q: What does Genomic Valley Biotech Ltd do?A: Genomic Valley Biotech Ltd focuses on biotechnology research and development, particularly in genomics and personalized medicine.
- Q: Is Genomic Valley Biotech Ltd a good investment?A: Investing in any stock carries risks. It's important to conduct thorough research and consider your financial situation.
- Q: What are the main risks associated with investing in biotech stocks?A: Biotech stocks can be volatile due to regulatory approvals, market competition, and research outcomes.
- Q: How can I stay updated on Genomic Valley Biotech Ltd?A: Follow their official website, press releases, and financial news for the latest updates.
- Q: What factors influence the stock price of Genomic Valley Biotech Ltd?A: Stock prices can be influenced by company performance, industry trends, regulatory news, and market sentiment.
📊 Stock Investment Checklist (100 Points)
Genomic Valley Biotech Ltd • Updated: 2025-09-18 00:26:54
-
10BusinessHighThe biotech sector is promising, but the company's competitive edge is unclear.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuating profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, with cash flow concerns.
-
5ValuationGoodValuation metrics are high compared to peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are some pledging issues.
-
4DriversGoodLimited growth catalysts identified, with execution risks present.
-
3TechnicalsLowWeak market sentiment and low liquidity affecting price action.
Final Score & Verdict
Score 58 / 100
• Decent
Genomic Valley Biotech Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 75/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100